SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the December 2021 quarter moved down -30.83% to Rs. 174.30 millions as compared to Rs. 251.99 millions during the year ago period.The Net Loss for the quarter ended December 2021 is Rs. -3.31 millions as compared to Net Loss of Rs. -18.94 millions of corresponding quarter ended December 2020 Operating profit Margin for the quarter ended December 2021 improved to 11.38% as compared to -10.74% of corresponding quarter ended December 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 174.30 251.99 -30.83 563.47 697.10 -19.17 853.34 668.37 27.67
Other Income 1.24 12.00 -89.67 5.90 7.56 -21.96 98.32 11.84 730.41
PBIDT 11.38 -10.74 -205.96 -8.47 -53.88 -84.28 -122.28 -92.25 32.55
Interest 15.38 12.96 18.67 39.22 35.53 10.39 47.70 47.42 0.59
PBDT -4.00 -23.70 -83.12 -47.69 -89.41 -46.66 -169.98 -139.67 21.70
Depreciation 0.41 0.59 -30.51 1.57 1.77 -11.30 2.37 2.37 0.00
PBT -4.41 -24.29 -81.84 -49.26 -91.18 -45.97 -172.35 -142.04 21.34
TAX -1.10 -5.35 -79.44 28.38 -25.73 -210.30 -41.55 -39.92 4.08
Deferred Tax -1.10 -5.35 -79.44 28.38 -25.73 -210.30 -41.55 -39.92 4.08
PAT -3.31 -18.94 -82.52 -77.64 -65.45 18.62 -130.80 -102.12 28.08
Equity 431.80 431.80 0.00 431.80 431.80 0.00 431.80 431.80 0.00
PBIDTM(%) 6.53 -4.26 -253.19 -1.50 -7.73 -80.55 -14.33 -13.80 3.82

Bharat Immunological Share Price

18.01 0.12 (0.67%)
20-Apr-2026 14:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1233.00
Cipla 1232.25
Zydus Lifesciences 937.65
Lupin 2328.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×